Cardiovascular disease in renal failure

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiovascular disease (CVD) is a leading cause of mortality in patients with chronic kidney disease (CKD), accounting for up to 50% of deaths.
• Left ventricular hypertrophy (LVH) is the most prevalent cardiac abnormality in end-stage renal disease (ESRD) patients.
• LVH results from a complex interplay of hemodynamic and humoral factors.

Purpose of the Study:

• To investigate the mechanisms linking CKD to cardiac alterations, specifically LVH.
• To explore the role of hemodynamic factors (volume and pressure overload) in cardiac remodeling.
• To assess the potential of therapeutic interventions targeting hemodynamic overload.

Main Methods:

• Review of existing literature on cardiovascular complications in CKD and ESRD.
• Analysis of the pathophysiological pathways involving hemodynamic and humoral factors.
• Examination of the adaptive and maladaptive cardiac responses to overload states.

Main Results:

• Volume and pressure overload induce adaptive cardiac and vascular alterations.
• Persistent overload leads to maladaptive changes, including cardiac dilation and heart failure.
• These detrimental processes are linked to the progression of CKD.

Conclusions:

• Hemodynamic overload is a critical factor in the development of LVH and heart failure in ESRD patients.
• Early and effective management of hemodynamic overload may be crucial for cardiovascular health in CKD.
• Interventions aimed at reducing hemodynamic stress could potentially stabilize or reverse cardiac damage.